These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


597 related items for PubMed ID: 16607900

  • 1. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
    Sjögren J, Gudbjartsson T, Thulin LI.
    J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
    [Abstract] [Full Text] [Related]

  • 2. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
    Minami K, Boethig D, Mirow N, Kleikamp G, Koertke H, Godehardt E, Koerfer R.
    J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis.
    Accola KD, Scott ML, Palmer GJ, Thompson PA, Sand ME, Suarez-Cavalier JE, Bott JN, Ebra G.
    J Heart Valve Dis; 2008 Jul; 17(4):355-64; discussion 365. PubMed ID: 18751463
    [Abstract] [Full Text] [Related]

  • 7. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ, Llorens R, Catalan M, Segura I, Trenor AM, de Buruaga JS, Rabago G, Sarralde A.
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
    García-Bengochea J, Sierra J, González-Juanatey JR, Rubio J, Vega M, Fernández AL, Sánchez D.
    J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term results with the Xenomedica porcine bioprosthesis in the mitral position.
    Santini F, Auriemma S, Casali G, Rossi A, Lusini M, Mazzucco A.
    J Heart Valve Dis; 2001 Nov; 10(6):789-94. PubMed ID: 11767188
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.
    Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R.
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve.
    Desai ND, Merin O, Cohen GN, Herman J, Mobilos S, Sever JY, Fremes SE, Goldman BS, Christakis GT.
    Ann Thorac Surg; 2004 Dec; 78(6):2076-83; discussion 2076-83. PubMed ID: 15561040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is routine use of stentless aortic prostheses justified in an elderly (aged > or =75 years) population?
    Ali A, Kumar P, Athanasiou T, Halstead J, Ashrafian H, Ali Z, Kumar S, Theodorou P, Pepper JR.
    J Heart Valve Dis; 2005 Jan; 14(1):64-70; discussion 70-1. PubMed ID: 15700438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.
    Wei X, Yi W, Chen W, Ma X, Lau WB, Wang H, Yi D.
    Ann Thorac Surg; 2010 May; 89(5):1417-24. PubMed ID: 20417754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.